201 related articles for article (PubMed ID: 17357108)
1. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death.
Acosta-Rodríguez EV; Craxton A; Hendricks DW; Merino MC; Montes CL; Clark EA; Gruppi A
Eur J Immunol; 2007 Apr; 37(4):990-1000. PubMed ID: 17357108
[TBL] [Abstract][Full Text] [Related]
2. TACI attenuates antibody production costimulated by BAFF-R and CD40.
Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
[TBL] [Abstract][Full Text] [Related]
3. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
4. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
Hayashi EA; Granato A; Paiva LS; Bertho AL; Bellio M; Nobrega A
J Immunol; 2010 May; 184(9):4662-72. PubMed ID: 20357250
[TBL] [Abstract][Full Text] [Related]
5. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
6. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
[TBL] [Abstract][Full Text] [Related]
7. Reduced susceptibility to Fas-mediated apoptosis in B-1 cells.
Masuda K; Wang J; Watanabe T
Eur J Immunol; 1997 Feb; 27(2):449-55. PubMed ID: 9045916
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of Fas antigen on activated murine B cells.
Wang J; Taniuchi I; Maekawa Y; Howard M; Cooper MD; Watanabe T
Eur J Immunol; 1996 Jan; 26(1):92-6. PubMed ID: 8566089
[TBL] [Abstract][Full Text] [Related]
9. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
10. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95).
Hancz A; Hérincs Z; Neer Z; Sármay G; Koncz G
Immunol Lett; 2008 Mar; 116(2):211-7. PubMed ID: 18243342
[TBL] [Abstract][Full Text] [Related]
11. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes.
Hornung F; Zheng L; Lenardo MJ
J Immunol; 1997 Oct; 159(8):3816-22. PubMed ID: 9378969
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
14. Bcl-x protects primary B cells against Fas-mediated apoptosis.
Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
[TBL] [Abstract][Full Text] [Related]
15. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
16. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
17. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
18. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis.
Fournel S; Genestier L; Robinet E; Flacher M; Revillard JP
J Immunol; 1996 Nov; 157(10):4309-15. PubMed ID: 8906804
[TBL] [Abstract][Full Text] [Related]
19. BLyS and B cell homeostasis.
Woodland RT; Schmidt MR; Thompson CB
Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
[TBL] [Abstract][Full Text] [Related]
20. Double knockout mice show BASH and PKCdelta have different epistatic relationships in B cell maturation and CD40-mediated activation.
Nojima T; Hayashi K; Goitsuka R; Nakayama K; Nakayama K; Kitamura D
Immunol Lett; 2006 May; 105(1):48-54. PubMed ID: 16481047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]